[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hepatosplenic-gamma-delta-non-hodgkin-lymphoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":16,"states":17},"Hepatosplenic Gamma\u002FDelta Non-Hodgkin Lymphoma",1,0,[8],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07137481","Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies",[12],"Phase 2","NOT_YET_RECRUITING","2026-08-26T02:19:17.380174Z","2026-05-05T02:43:28.805067Z",[],[]]